Am J Physiol 258: G196-201, 1990
Typically, people with a personal or family history of certain types of thyroid cancer, those with a history of pancreatitis or gastroparesis, and those who are pregnant or planning to be should not take these medications
In clinical trials, retatrutide has been administered as a once-weekly subcutaneous injection, with a structured dose-escalation schedule used to improve tolerability
GLP-1 receptor agonists should be avoided in pregnancy and discontinued at least 2 months before planned conception, whilst metformin is commonly used during pregnancy
Without that support, patients may lose muscle, struggle with nutrition, stop too soon, or feel abandoned when side effects occur or weight returns
Bruker) on the Evosep ONE HPLC system using the 30 samples per day method, then injected through a CaptiveSpray ion source and 20 m emitter into a timsTOF Pro 2 mass spectrometer (Bruker) operated in diaPASEF mode